The Methyl-CpG-binding domain (MBD) is crucial for MeCP2’s dysfunction-induced defects in adult newborn neurons
Mutations in the human X-linked gene MECP2 are responsible for most Rett syndrome (RTT) cases, predominantly within its methyl-CpG-binding domain (MBD). To examine the role of MBD in the pathogenesis of RTT, we generated two MeCP2 mutant constructs, one with a deletion of MBD (MeCP2-ΔMBD), another...
Main Authors: | Na eZhao, Dongliang eMa, Wan Ying eLeong, Ju eHan, Antonius eVanDongen, Teng eChen, Eyleen L Goh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-04-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fncel.2015.00158/full |
Similar Items
-
MeCP2 Deficiency in Neuroglia: New Progress in the Pathogenesis of Rett Syndrome
by: Xu-Rui Jin, et al.
Published: (2017-10-01) -
MeCP2_e2 partially compensates for lack of MeCP2_e1: A male case of Rett syndrome
by: Ryo Takeguchi, et al.
Published: (2020-02-01) -
Metformin Induces MeCP2 in the Hippocampus of Male Mice with Sex-Specific and Brain-Region-Dependent Molecular Impact
by: Khatereh Saei Arezoumand, et al.
Published: (2024-04-01) -
A novel DNA-binding feature of MeCP2 contributes to Rett syndrome
by: Xin eXu, et al.
Published: (2013-05-01) -
Manipulations of MeCP2 in glutamatergic neurons highlight their contributions to Rett and other neurological disorders
by: Xiangling Meng, et al.
Published: (2016-06-01)